1. Introduction
According to the World Health Organization, more than 286 million people worldwide suffer from brain disease [
1]. According to reports [
2], 246 million people are mentally ill, and 39 million are in critical condition. As one of the largest and most complex parts of the body, the brain plays an important role in numerous functions, such as generating ideas, problem-solving, reasoning, decision-making, imagination and memory [
1]. Alzheimer’s disease (AD), which affects millions of people, is the most common type of dementia. As people age, their anxiety about developing Alzheimer’s increases. Alzheimer’s disease slowly destroys brain cells and leaves patients unable to recognize family members. As a result, they become confused and lose the ability to recognize their surroundings. In advanced stages, they also lose the ability to eat, cough, and breathe [
3].
The number of Alzheimer’s patients is expected to increase exponentially by 2050, with 152 million new cases of AD and dementia being diagnosed annually, or one every three seconds. AD symptoms, such as memory impairment, language and communication difficulties, and behavioral and psychological symptoms, overlap with vascular dementia (VD), making the diagnosis of AD challenging[
4] [
5]. Early and accurate diagnosis of AD is crucial for patient care, treatment, and prevention by monitoring its progression. Brain tumors are another severe condition that can be life-threatening to the brain. Since the blood vessels and nerves of the brain are at risk, tumors often develop there. Depending on the stage and malignancy of the tumor, it can cause partial or complete blindness [
6]. Family history, ethnicity, and severe myopia are other contributing factors [
7]. As a result, today’s most advanced societies increasingly need to discover rapid and automated early detection techniques. Medical imaging has also become a powerful tool for understanding brain activity. Magnetic resonance imaging (MRI) is a type of brain imaging that allows visualization of the structure and function of the brain. Medical professionals evaluate patients for signs and symptoms of AD and brain tumors. MRI can identify brain abnormalities associated with mild cognitive impairment (MCI) and predict which MCI patients will develop AD and brain tumors. MRI images are examined for abnormalities, such as reductions in the size of various brain regions that primarily affect memory[
8].
Functional magnetic resonance imaging (fMRI) is yet another addition to the existing brain imaging techniques and methods for AD classification. It measures brain function by imaging blood flow alterations over time. This mechanism works based on blood flow’s coupling to neuronal activity. When a particular brain area is engaged, the blood flow to this specific area is also increased. Added to these imaging methods, resting-state functional MRI (rs-fMRI) has found several applications in research and has proven very high sensitivity for AD [
9]. Using rs-fMRI, Greider et al. [
10] found that reduced complexity of neural connectivity is directly associated with AD. Furthermore, rs-fMRI has been reported to reveal functional connectivity associated with cognitive impairments in elderly populations with health problems, MCI, and AD. Using traditional machine learning is challenging due to manual feature selection. Deep learning, as a multi-layered learning approach, attempts to learn using automatic feature selection. Deep learning has achieved remarkable results in medical applications [
11,
12,
13], language models [
14,
15], and natural language processing[
16,
17]. In the field of neuroscience, various deep learning models have been employed to analyze fMRI data. Typically, analysis to distinguish between AD and CN states is performed using CNN models [
18,
19,
20]. However, fMRI data have been used for binary classification in most studies. Further research needs to be done on multi-class classification of fMRI data.
In [
21], the authors examined a case study of traditional machine learning approaches to predict Alzheimer’s Disease. Four standard machine learning models, including SVM, Logistic Regression, Decision Tree, and Random Forest, were used for the classification. The OASIS dataset was also used to evaluate these approaches. SVM obtained the best result in this study, and Logistic Regression obtained the worst result. SVM on OASIS data was able to achieve accuracy=0.92. The use of different features in classification is one of the advantages of this study, and the lack of comparison with deep learning approaches is one of its disadvantages. In [
22], using SVM as a classification technique and improving feature selection in diagnosing AD is presented as a structured traditional ML approach. The accuracy of the method is reported to be 92.48%. The sensitivity and specificity were reported to be 86.92% and 90.76%, respectively.
The authors in [
23] presented a method for diagnosing Alzheimer’s disease using image processing techniques and genetic algorithms for classification and prediction. The present study involves transforming Alzheimer’s disease into a cognitive disorder that serves as the initial feature of the input MRI images. This research used a genetic algorithm to predict and diagnose Alzheimer’s disease, and a support vector machine was used as a classification technique. The method reported a precision of 93.01%, a recall rate of 89.13%, and a feature recognition rate of 96.80%. The present study focuses on methods that use the ADNI dataset as the initial input data. Also, [
24] reviewed traditional machine learning approaches for AD Diagnosis. [
25] compared the performance of the machine learning models for Alzheimer’s Disease Early Detection. Logistic Regression, Decision Tree, Support Vector Machine, K-nearest Neighbors, Random Forest, Naïve Bayes, and Linear Discriminant Analysis models were used for classification. Also, the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and the Open Access Series of Imaging Studies (OASIS) brain datasets were considered to evaluate these approaches. The Logistic Regression approach achieved the highest accuracy in both datasets. Selecting the correct features to provide a classifier is one of the advantages of this research. [
26,?,
27] other examples of studies that used traditional machine learning to classify Alzheimer’s.
[
28] employed powerful deep learning models, such as VGG16, along with machine learning classifiers to thoroughly analyze MRI and PET scans for the detection of Alzheimer’s disease. Longer computation times accompanied the Support Vector Machine’s achievement of the highest accuracy (84%). Faster processing and strong predictive capabilities shown Random Forest’s potential. A hybrid deep learning approach for early detection was shown by several multimodal imaging studies using Convolutional Neural Networks along with LSTM algorithms. We explored several techniques to improve detection efficiency, including transfer learning, the selection of images based on entropy, as well as K-Means Clustering along with the Watershed method. Feature fusion importantly improved visual data representation, along with its analysis. RF’s robustness along with speed suits it for further Alzheimer’s research, despite SVM’s superior performance.
OViTAD [
29] an optimized vision transformer. OViTAD uses AWS SageMaker infrastructure to predict healthy brains along with mild cognitive impairment MCI brains as well as Alzheimer’s disease AD brains using rs-fMRI and structural MRI data. OViTAD, through precise parameter optimization along with perceptive visualization of its attention mechanisms, importantly exceeded other deep learning models, as well as CNN-based ones, in multi-class classification; achieving outstandingly high average performances of 97% ± 0.0 and 99.55% ± 0.39 across three repetitions. [
30] presented an effective segmentation approach (SAS) and a new classification model (HBOA-MLP) for Alzheimer’s disease early diagnosis based on fMRI images. It aimed at improving the accuracy of classification and shortening the computational time. Following preprocessing, SAS segmented the brain regions effectively, and feature vectors were extracted by Gabor and GLCM techniques. The vectors were optimized by the Honey Badger Optimization Algorithm (HBOA) and then used in a Multi-Layer Perceptron (MLP) model for classification. The HBOA-MLP model achieved a high accuracy of 99.44%; still, it faced a problem in dealing with large datasets due to the fully connected structure of the MLP network and its high number of parameters.
[
31] proposes an automatic Alzheimer’s diagnosis system based on different frequency bands of rs-fMRI data and deep learning models. The system uses a high-order neuro-dynamic functional network taking slow4, slow5, and full-band ranges. Customized Alexnet and Inception blocks were utilized with SVM and KNN approaches for development. The presented deep ensemble networks demonstrated better performance without external feature selection. Slow5 features trained with customized networks attained better AD/MCI classifications. The results suggest that the characteristics of multiband rs-fMRI may serve as biomarkers for Alzheimer’s disease, facilitating a more efficient diagnostic framework.
Authors in [
32] fused (sMRI) and (rs-fMRI) features to classify MCInc and AD from MCIc based on graph theory and machine learning. The model utilized cortical thickness, structural brain network, and sub-frequency functional brain network features. Feature selection techniques of RSFS, mRMR, and SS-LR were utilized, and SVM classifier and nested cross-validation were performed for classification. RSFS demonstrated the best accuracies in the classification between MCIc vs. MCInc and MCIc vs. AD. Combining several features enhanced classifying MCIc subjects from MCInc/AD. The framework that combined sMRI and fMRI data predicted MCI conversion, suggesting its potential to offer AD diagnostic markers [
33] puts forward a new framework with rs-fMRI, PSI, and 2D-CNN for the abnormal brain functional connectivity detection in AD. This framework achieved the classification accuracy of 98.869% by fusing the brain topological and deep features. The framework using SVM classifier and 5-fold cross-validation classifies the AD and non-AD samples by extracting eight topological and deep features. The PSI network analysis reveals weaker connection strength and reduced small-world property in the brains of AD patients. The 2D-CNN model identifies deep features that represent abnormal connectivity patterns in AD patients, which contributes to understanding the pathogenesis of AD. This framework shows great potential for AD classification and elucidating the pathogenesis. [
34] employs ResNet-18 architecture and rs-fMRI data to classify the stages of Alzheimer’s disease (AD). Three ResNet-18-based networks are trained and tested: 1CR, OTS, and FT. The FT network achieved the highest accuracy, which demonstrates the benefits of residual learning, pre-training, and transfer learning. The OTS network obtained the best average testing accuracy, which further proves the potential of deep learning approaches for AD classification.
Authors in [
35] puts forward a deep learning framework for early Alzheimer’s disease detection with the use of resting-state fMRI data and clinical data. The framework involves specialized autoencoders in disentangling natural aging and disorder progression. It facilitates classification performance, reduces standard deviation over traditional classifiers, and avoids overfitting in a three-layer architecture for improved diagnostic accuracy by 25% over conventional approaches. This approach has the potential to merge brain network analysis with deep learning techniques for neurological disorder diagnosis in the earliest stages. [
36] proposes a 3D-CNN-LSTM model for Alzheimer’s and other health diagnosis with 4D fMRI data. This model can extract spatial and temporal features effectively, with an accuracy of 96.4% using five-fold cross-validation. It outperforms the 3D-CNN model by utilizing both spatial and temporal information and has great potential to determine Alzheimer’s progression using analysis of 4D fMRI data.
The primary focus of this study is on the recent literature on automated classification and assessment of Alzheimer’s disease. We propose an integrated deep-learning architecture for Alzheimer’s disease classification with image data to achieve accurate and reliable classification in various clinical settings. The advanced techniques investigated have the potential to improve automated analysis and support clinical decision-making, thereby enabling early detection of the disease.